A Physiologically Based Clinical Measure for Spastic Reflexes in Spinal Cord Injury by Benz, Ela N. et al.
Marquette University 
e-Publications@Marquette 
Biomedical Engineering Faculty Research and 
Publications Biomedical Engineering, Department of 
1-2005 
A Physiologically Based Clinical Measure for Spastic Reflexes in 
Spinal Cord Injury 
Ela N. Benz 
Rehabilitation Institute of Chicago 
T. George Hornby 
Rehabilitation Institute of Chicago 
Rita K. Bode 
Rehabilitation Institute of Chicago 
Robert A. Scheidt 
Marquette University, robert.scheidt@marquette.edu 
Brian D. Schmit 
Marquette University, brian.schmit@marquette.edu 
Follow this and additional works at: https://epublications.marquette.edu/bioengin_fac 
 Part of the Biomedical Engineering and Bioengineering Commons 
Recommended Citation 
Benz, Ela N.; Hornby, T. George; Bode, Rita K.; Scheidt, Robert A.; and Schmit, Brian D., "A Physiologically 
Based Clinical Measure for Spastic Reflexes in Spinal Cord Injury" (2005). Biomedical Engineering Faculty 






Biomedical Engineering Faculty Research and Publications/College of 
Engineering 
 
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The 
published version may be accessed by following the link in the citation below. 
 
Archives of Physical Medicine and Rehabilitation, Vol. 86, No. 1 (January 2005): 52-59. DOI. This article 
is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. 
Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere 
without the express permission from Elsevier.  
 
A Physiologically Based Clinical Measure for 
Spastic Reflexes in Spinal Cord Injury 
 
Presented in part to the American Spinal Injury Association, May 19, 2001, Long Beach, CA, and the American 
Physical Therapy Association’s Combined Sections, February 15, 2003, Tampa, FL. 
 
Ela N. Benz 
Sensory Motor Performance Program, Rehabilitation Institute of Chicago, Chicago, IL 
T.George Hornby 
Sensory Motor Performance Program, Rehabilitation Institute of Chicago, Chicago, IL 
Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL 
Rita K. Bode 
Center for Rehabilitation Outcomes Research, Rehabilitation Institute of Chicago, Chicago, IL 
Robert A. Scheidt 
Center for Rehabilitation Outcomes Research, Rehabilitation Institute of Chicago, Chicago, IL 
Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL 
Department of Biomedical Engineering, Marquette University, Milwaukee, WI 
Brian D. Schmit 
Sensory Motor Performance Program, Rehabilitation Institute of Chicago, Chicago, IL 
Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL 
Department of Biomedical Engineering, Marquette University, Milwaukee, WI 
 
Abstract 
Benz EN, Hornby TG, Bode RK, Scheidt RA, Schmit BD. A physiologically based clinical measure for spastic 
reflexes in spinal cord injury. Arch Phys Med Rehabil 2005;86:52-9. 
Objective 
To test the validity of the Spinal Cord Assessment Tool for Spastic reflexes (SCATS), a clinical tool intended to 
rate spastic motor behavior after spinal cord injury (SCI). 
Design 
By using correlational analyses, the SCATS was validated using concurrent measurements of kinematics and 
electromyograms and traditional assessments of spasms and spastic hypertonia. 
Setting 
Research laboratory (kinematics and electromyography) and outpatient medical clinic (traditional measures of 
spastic hypertonia). 
Participants 
Eleven people with SCI were used for kinematic and electromyographic measurements. Seventeen people with 
SCI were used for comparison with other clinical scales. 
Interventions 
Not applicable. 
Main outcome measures 
Kinematic and surface electromyographic measurements of the tested lower extremity were used to quantify 
magnitude and/or duration of motor behaviors, and the Penn Spasm Frequency Scale (PSFS) and the Ashworth 
Scale were used to measure spasm frequency and resistance to joint movement for the hip flexors, knee flexors, 
and ankle plantarflexors, respectively. Concurrently, the SCATS was used to assess the clonus response to an 
imposed ankle dorsiflexion, the flexion response to a stimulus to the foot, and the knee extensor activity in 
response to an imposed leg extension. Each component of the SCATS was compared with the Ashworth Scale, 
the PSFS, and kinematic and electromyographic measurements by using the Spearman rank correlation test. 
Results 
Clonus, flexor spasm, and extensor spasm responses measured by using the SCATS correlated significantly with 
kinematic and electromyographic recordings (P<.01). Significant correlations were also observed between the 
SCATS extensor spasms and the Ashworth scores for hip and knee flexors and for ankle plantarflexors (ρ=.98, 
.88, .61, respectively). Also, SCATS flexor spasms and SCATS clonus scores correlated significantly with some of 
the Ashworth scores. Only SCATS clonus scores correlated significantly with spasm frequency measures 
(ρ=.59, P<.05). 
Conclusions 
The SCATS produced a valid measure of 3 distinct types of spastic motor behaviors in SCI and may provide a 
complementary tool for measuring spastic hypertonia. Such a measure is valuable because current assessment 
tools do not differentiate between the different types of spastic motor behaviors that manifest after SCI. 
Distinguishing the 3 spastic reactions using an efficient and valid clinical tool may help guide management of 
spastic hypertonia in SCI. 
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People With Spinal Cord Injury (SCI) often experience exaggerated reflex responses affecting muscles that are 
deficient in voluntary control. These reflexes arise from both proprioceptive and exteroceptive inputs, are 
described as the positive signs of the upper motoneuron syndrome, and manifest as spasticity and 
dystonia.1, 2, 3 The functional implications of these spastic motor behaviors are underscored by patient and 
clinician reports that spasticity interferes with mobility and activities of daily living (ADLs).3 
Attempts to quantify spastic hypertonia in SCI have had mixed results. Assessment tools used most often by 
clinicians to measure spastic hypertonia are the Ashworth Scale4 and the Modified Ashworth Scale (MAS), which 
measure spastic behaviors based on the following traditional definition: “a motor disorder characterized by a 
velocity-dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks resulting from 
hyperexcitability of the stretch reflex, as one component of the upper motor neuron syndrome.”5(p485) This 
definition focuses on resistance to movement at a single joint, which is primarily sensitive to stretch reflex 
hyperexcitability. The MAS is effective for globally assessing spastic hypertonia in patients with 
tetraplegia6, 7, 8; however, limitations to the Ashworth scales have been expressed.9, 10, 11 
In addition to stretch reflex excitability, spastic motor behavior in SCI also includes hyperexcitable interneuronal 
reflexes involving multiple joints (ie, spasms).12, 13, 14, 15, 16 To address involuntary motor behaviors that 
incorporate multijoint spasms, a scale devised by Penn et al was developed by using patient reports of spasm 
frequency.17 Other investigators18 have addressed the multidimensional nature of spinal spastic hypertonia by 
combining clinical and self-report measures. Despite recognition that the manifestation of spastic motor 
behaviors in SCI is more complex than measures of spasm frequency and resistance to single joint movement, a 
standardized, simple clinical measure that encompasses the primary spastic reactions has yet to evolve. 
The multidimensional nature of reflex hyperexcitability in SCI is often shown by 3 distinct types of spasms that 
are reported by patients and clinicians: clonus (particularly at the ankle), flexor spasms, and extensor 
spasms.3 Clonus is an involuntary rhythmic muscle contraction occurring at a frequency of 3 to 8Hz, and it is 
typically elicited by rapid passive movement of the ankle into dorsiflexion.19 Flexor spasms are described as 
multijoint flexion movements of the leg after various cutaneous stimuli,13 and extensor spasms are multijoint 
leg extension movements often evident after changes in hip position.15 Because each of these types of spastic 
responses involves different reflex pathways, and therefore different pathophysiologic mechanisms, a clinical 
tool that is easily administered and that is sensitive to the type of spastic hypertonia seen in SCI would be of 
considerable value to clinicians. 
To address the need for a clinical scale to measure spasms and spastic hypertonia in SCI, the Spinal Cord 
Assessment Tool for Spastic reflexes (SCATS) was developed. The goal of this study was 2-fold. The first goal was 
to validate the SCATS by using kinematic and electromyographic measurements to quantify magnitude and/or 
duration of motor behaviors and to establish their correlation with clinician-determined spasm ratings. Second, 
we aimed to show that the SCATS would differentiate among the 3 types of spastic reflexes, and we wished to 
compare the SCATS to other clinical measures of spastic hypertonia that are commonly used in the clinical 
setting, including the Ashworth Scale and the Penn Spasm Frequency Scale (PSFS).17 
Methods 
Participants 
All subjects were recruited from the inpatient and outpatient clinics of the Rehabilitation Institute of Chicago. 
Inclusion criteria for all components of our study included history of SCI, age 16 to 65 years, and patient or 
clinician report of spastic motor behaviors. Exclusion criteria included acute orthopedic injuries, heterotopic 
ossificans, decubiti, and acute urinary tract infections. Informed consent was obtained for each subject, and all 
procedures were conducted in accordance with the Helsinki Declaration of 1975 and approved by the 
institutional review boards of Northwestern University and Marquette University. All subject demographics are 
summarized in table 1. 
Table 1. Subject Descriptions for Comparison of the SCATS With Kinematic Electromyographic Measures and for Comparison of the SCATS With the 
Ashworth Scale and PSFS 
















Kinematic and electromyographic 
measures 
   
     
1 A T3 45 None 48 2 1 1 
2 D T4 40 None 46 2 1 0 
3 A C7 35 40mg baclofen tid 30 0 2 1 
4 A T4 35 None 30 3 2 2 
5 A C5 17 None 3 0 0 0 
6 D T9 45 20mg baclofen tid 360 0 1 0 
7 A C5 22 10mg baclofen tid 40 0 2 2 
8 A C6 47 None 24 1 1 1 
9 A C6 30 10mg baclofen qid 18 0 1 1 
10 A C5 44 None 24 0 3 0 
11 A T4 40 None 360 0 1 1 
Ashworth Scale and PSFS   
      
12 A C5 28 20mg baclofen qid 48 0 1 0 
13 A C6 52 10mg diazepam tid 264 0 3 0 
14 D C5 32 10mg baclofen tid 180 0 2 2 
15 C C6 39 40mg baclofen qid 192 1 0 2 
16 A T10 48 None 372 3 3 3 
17 B C6 40 40mg baclofen qid 204 0 0 0 
18 A T3 51 40mg baclofen qid 24 0 3 0 
19 A C7 30 40mg baclofen qid 36 1 0 0 
20 A C45 63 40mg baclofen tid 360 0 1 0 
21 C C7 35 None 30 3 1 3 
22 A T4 62 None 180 0 0 0 
23 A T7 39 10mg baclofen tid 270 2 3 0 
24 A C5 22 None 40 0 2 2 
25 A T3 45 None 48 2 1 1 
26 A C6 45 None 120 1 2 1 
27 A C7 47 None 130 2 1 1 
Abbreviations: ASIA, American Spinal Injury Association; qid, 4 times daily; tid, 3 times daily. 
For kinematic and electromyographic analysis, 11 subjects were recruited via flyers posted in the testing facility, 
and a telephone interview was conducted to ensure compliance with all inclusion and exclusion criteria. For 
comparison with the Ashworth Scale and the PSFS, 17 subjects were recruited via referral by their primary care 
physician during outpatient medical visits. 
Instruments 
The SCATS 
The development of the SCATS was based on previous clinical measures of spastic hypertonia that use a physical 
examination to assess involuntary motor behaviors, as well as recent laboratory measurements of clonus, flexor, 
and extensor spasms.15, 16, 19 Specific techniques for measurement of these spasms follow. 
SCATS: clonus 
Clonus of the plantarflexors was quantified in response to a rapid passive dorsiflexion of the ankle (fig 1A). The 
ankle was dorsiflexed at an angle that triggered clonus, and the duration of clonic bursts was timed. An ordinal 
rating from 0 to 3 was determined by the duration of clonic activity where 0 is no reaction; 1 is mild, clonus was 
maintained less than 3 seconds; 2 is moderate, clonus persisted between 3 and 10 seconds; and 3 is severe, 
clonus persisted for more than 10 seconds. 
 
 
Fig 1. Procedures for the SCATS measurement. (A) Clonus was assessed by using an imposed dorsiflexion 
movement of the ankle, with 1 hand placed under the calf and the other placed on the foot. 
(Continued) (B, C) The flexor response to a pinprick perturbation to the bottom of the foot was assessed visually. 
(D, E) The response to simultaneous hip and knee extension was observed to document extensor spasms. The 
starting position of the movement is shown at the left, and the terminal position is shown on the right. 
SCATS: flexor spasms 
With the knee and hip extended to 0°, the clinician applied a pinprick stimulus for 1 second to the medial arch of 
the subject’s foot (fig 1B). Excursion of the big toe into extension, ankle dorsiflexion, and knee and hip flexion 
were visually observed for severity. The rating scale consisted of a score from 0 to 3, where 0 is no reaction to 
stimulus; 1 is mild, less than 10° of excursion in flexion at the knee and hip or extension of the great toe; 2 is 
moderate, 10° to 30° of flexion at the knee and hip; and 3 is severe, 30° or greater of knee and hip flexion. 
SCATS: extensor spasms 
With the contralateral limb extended, the tested knee and hip were positioned at angle of 90° to 110° of hip and 
knee flexion, and then both joints were simultaneously extended. One hand cupped the heel while the other 
was placed on the outside of the thigh (fig 1C). Once a reaction was elicited, the duration of visible muscle 
contraction in the quadriceps muscle was measured by observing superior displacement of the patella. The 
timed scale (0–3) that was used for clonus was also applied to the timed extensor spasms. 
Kinematic measurements 
An Optotrak 3020 motion analysis systema was used to measure the kinematics of each perturbation by using 12 
markers placed on the following anatomic landmarks: second distal interphalangeal joint, first metatarsal 
head, lateral malleolus, tibial shank, patella, lateral femoral condyle, lateral quadriceps, greater trochanter, 
anterior superior iliac spine, bisection of the pelvis at iliac crest, xiphoid process, and a hand width under 
the axilla. Marker location data were digitally sampled at 1000Hz for 20 seconds by a personal computer (PC), 
for each trial. 
Electromyograms 
Electromyograms (EMGs) were recorded from the tibialis anterior, soleus, medial 
gastrocnemius, vastus medialis, rectus femoris, medial hamstrings, adductors, and contralateral rectus femoris. 
Active surface electrodesb were applied to lightly abraded skin over the respective muscles. Electromyographic 
signals were amplified (10,000×) and sampled at 1000Hz by using the same PC used to acquire the kinematic 
data. 
Ashworth Scale 
The Ashworth Scale4 was used to quantify tone of the ankle plantarflexors, knee flexors, and hip flexors. This 
scale uses ratings from 0 to 4 to assess the resistance to a movement applied throughout the entire range of 
motion. The scores correspond to 0 being no increase in tone; 1 being a slight increase in tone, giving a catch 
when the limb is moved into flexion or extension; 2 being a more marked increase in tone but limb easily flexed; 
3 being a considerable increase in tone, with passive movement difficult; and 4 being a limb rigid in flexion or 
extension. 
Penn spasm frequency scale 
The PSFS17 was also used to quantify spasticity in 17 participants. This scale is based on self-reporting by using a 
scale from 0 to 4, with the following rankings: 0, no spasm; 1, mild spasms induced by stimulation; 2, infrequent 
full spasms occurring less than once per hour; 3, spasms occurring more than once per hour; and 4, spasms 
occurring more than 10 times per hour. 
Procedures 
Two experimental paradigms were used in this study: (1) to assess the validity of the SCATS measurements 
based on concurrent kinematic and electromyographic measurements and (2) to estimate the relation of this 
new clinical assessment tool to those often used in a clinical setting. 
Kinematic and electromyographic measurements 
In the first set of experiments, 11 subjects with SCI of 3 months to 10 years in duration were assessed to validate 
the SCATS measurements. Repeated trials of each of the SCATS tests (clonus, flexor spasms, extensor spasms) 
were performed by the same tester on each subject’s right lower extremity (fig 1). Perturbations intended to 
elicit clonus, flexor spasms, and extensor spasms were applied sequentially, and each battery of tests was 
repeated 10 times, with simultaneous measures of SCATS scores, kinematic data, and electromyographic 
responses. 
Comparison with other clinical scales 
In the second set of experiments, a comparison of the SCATS with other clinical scales was conducted in 17 
subjects with SCI during routine outpatient medical visits. A single physical therapist administered 3 measures of 
spastic motor behaviors, including the PSFS, Ashworth Scale, and SCATS. The Ashworth Scale was measured in 
the right lower extremity for knee and hip extension and ankle dorsiflexion. Subjects were between 6 months 
and 10 years postinjury (table 1), with mixed injury levels (American Spinal Injury Association scale) and were 
taking various medications to control their upper motoneuron symptoms. Each test was performed once. 
Data analysis 
Kinematics 
Three-dimensional, lower-extremity kinematics obtained via infrared marker data were used to calculate the 
approximate angles between adjacent limb segments during SCATS testing. This analysis was conducted by using 
an assumption of rigid body motion. A vector representing the orientation of each body segment relative to the 
laboratory coordinate frame was defined using markers fixed to the proximal and distal anatomic landmarks of 
each body segment: torso, pelvis, thigh, shank, and foot. The angle between adjacent limb segments (ie, the 
joint angles) was estimated by using the vector dot product: 
θjoint=q̄1·q̄2|q̄1||q̄2| 
Concurrent validity was established by using a correlation analysis of kinematic and electromyographic signals 
with SCATS measurements. The time trajectory of each joint angle was displayed for analysis by a trained 
clinician; changes in joint angle were quantified by using an interactive, cursor-based analysis tool developed by 
using custom-designed Matlab software.c To assess flexor spasms after pinprick stimulation of the medial arch, 
joint angle changes in the hip, knee, and ankle were calculated by taking the difference between these angles 
measured before and after stimulation. For quantification of ankle clonus after rapid, passive ankle dorsiflexion, 
the duration and frequency of clonic bursts were determined by using the same graphics tool. The number of 
beats per second and the duration of the response were calculated as a measure of clonus. 
Electromyograms 
The durations of knee (vastus medialis) and ankle (soleus, medial gastrocnemius) extensor EMGs were used to 
provide objective verification of clinicians’ assessments of extensor spasm duration and clonus duration during 
SCATS testing. EMGs were band-pass filtered (cutoff frequencies, 20Hz, 2000Hz), amplified (gain, 10,000), and 
low-pass filtered (cutoff frequency, 500Hz), before being sampled at 1000 samples per second. The same cursor-
based tool used to analyze joint kinematics was applied in the analysis of EMG durations. The time trajectory of 
each electromyographic signal was displayed for every trial. Visual estimation of the onset and terminus of 
soleus and medial gastrocnemius EMGs was used. Spasm duration was calculated directly from these measures. 
Correlation of SCATS and kinematic and electromyographic parameters 
A correlational analysis was conducted between the clinician-measured SCATS score and magnitude or duration 
of the associated kinematic or electromyographic parameter. The extensor SCATS score was also correlated with 
vastus medialis electromyographic activity; the flexor SCATS with excursion of the ankle, knee, and hip into 
flexion and the sum of the joint angles; and the clonus SCATS with the duration of the EMG of the medial head 
of the gastrocnemius. The 10 trials of data for each subject were pooled across the 11 subjects, and a Spearman 
rank correlation test was used to obtain correlations between the SCATS and the targeted kinematic or 
electromyographic parameter (α=.05). The SCATS score was then calculated in each category based on the 
kinematic and electromyographic data, and the correlational analysis was repeated (Spearman rank correlation 
test at α=.05). 
Repeatability of test perturbations 
The mean and standard deviation (SD) of the input perturbations were calculated for each test as follows: for 
clonus, we measured the input ankle angular perturbation magnitude and the rate of change of this 
perturbation; for the extensor spasm stimulus, we measured the extension speed at the hip and knee, as well as 
the position of the hip and the knee where spasm was elicited. 
Comparison with Ashworth Scale and PSFS 
To determine correlations between the SCATS, Ashworth Scale, and PSFS scores, a Spearman rank correlation 
analysis was conducted (α=.05). Specifically, all flexor, extensor, and clonus ratings were compared with 
Ashworth scores determined during ankle dorsiflexion and hip and knee extension. Further comparisons were 
made between individual SCATS ratings and the subject-reported PSFS rating. 
Results 
Validation using kinematic and electromyographic analysis 
An example of typical input and output responses for each spastic response is given in figure 2. Figure 2A shows 
the rapid, passive ankle dorsiflexion, followed by rhythmic medial gastrocnemius-soleus electromyographic 
bursting and ankle plantarflexion movements typical of clonus. Rapid dorsiflexion movements were necessary to 
generate clonus in all subjects who manifested such behaviors (4/11 subjects). Mean amplitude of the manual 
dorsiflexion perturbations ± SD was 21°±5.6°, generated at a mean angular velocity of 166°±61°/s, with 
differences likely arising from velocity-dependent spastic responses typically observed with rapid stretch of 
plantarflexors in people with SCI. Similarly, figure 2C shows the rapid passive hip and knee extension, with a 
mean angle change of 108.81°±12.3° at the hip and 106.99°±8.81° at the knee. The average peak speed of the 
perturbation was 89.15°±18.5°/s at the hip, which was followed by prolonged knee extensor and ankle 
plantarflexor electromyographic activity in 7 of 11 subjects tested. Objective measurements of flexor 
spasm activity after pinprick, as shown in (fig 2B), were collected by using hip, knee, and ankle angle trajectories 
after medial arch stimulation. A typical electromyographic response from the lower-extremity musculature is 
also shown in this figure. 
 
Fig 2. Kinematic and electromyographic measurements for clonus, flexor spasms, and extensor spasms are 
shown. (A) The top trace shows the ankle position during a clonus perturbation and response. Dorsiflexion is 
upward. The initial movement perturbation is followed by clonic oscillations of the ankle. The response ankle 
movements are accompanied by bursts of activity in the plantarflexors (below). (B) The ankle, knee, and hip 
flexion responses to a pinprick stimulus applied to the foot are shown along with the electromyographic signal 
from the tibialis anterior. (C) The extension movement and ensuing electromyographic response of the leg 
extensors is shown. The initial and final joint flexion angles are indicated on the position traces. Extension of the 
leg was followed by knee and ankle extensor activity, which was observed as a displacement of the patella. 
Abbreviations: MG, medial gastrocnemius; SOL, soleus; TA, tibialis anterior; VM, vastus medialis. 
All SCATS measures correlated significantly with the corresponding EMG or kinematic measurement and with 
SCATS scores identified from electromyographic or kinematic data, as summarized in table 2. 
Table 2. Correlation of the SCATS and Kinematic and Electromyographic Measures 
Measure 1 (laboratory based) Measure 2 (clinical measure) ρ P 
Vastus medialis duration Extensor SCATS .90 <.001 
Soleus duration Extensor SCATS .70 <.001 
Extensor SCATS Extensor SCATS .94 <.001 
Medial gastrocnemius duration Clonus SCATS .69 .002 
Clonus SCATS Clonus SCATS .90 <.001 
Ankle excursion angle Flexor SCATS .69 <.001 
Knee excursion angle Flexor SCATS .81 <.001 
Hip excursion angle Flexor SCATS .82 <.001 
Flexor SCATS Flexor SCATS .87 <.001 
 
Validation of the SCATS with the Ashworth Scale and PSFS 
The outcomes of statistical comparisons between the SCATS and the Ashworth Scale yielded variable 
results (table 3). Specifically, comparison of Ashworth scores from the hip, knee, and ankle all correlated 
significantly with SCATS extensor spasm scores. Conversely, SCATS flexor spasm ratings correlated significantly 
only with hip flexor Ashworth scores, while SCATS clonus scores were correlated only to knee and ankle 
Ashworth measures. In consideration of the established validity of SCATS (as determined earlier), the lack of 
consistent correlations between SCATS and Ashworth scores indicates differences in the manifestation of spastic 
responses across this subject population. 














PSFS .43 .43 .51 .59∗ .41 .40 
Ashworth hip 
 




.77† .65∗ .47 .88† 
Ashworth 
ankle 
   
.60∗ .40 .61∗ 
SCATS clonus 
    
.35 .59∗ 
SCATS flexion 
     
.56∗ 
∗Significant at P<.05. 
†Significant at P<.01. 
Comparison of PSFS ratings with SCATS scores revealed a significant correlation only with the SCATS clonic 
responses, which indicates that clonus may play a substantial role in patient reports of spasm frequency. 
Conversely, considering the preponderance of flexor and extensor spasm behaviors, as shown in the study, 
patient subjectivity may play a substantial role in the perception of the severity of spastic motor behaviors. 
Discussion 
The results of our study are promising for the use of the SCATS to quantify spastic motor behaviors in SCI. The 
SCATS provided a valid estimate of clonus, flexor, and extensor spasms, as evidenced by the kinematic and 
electromyographic analyses. Comparison of the SCATS with commonly used clinical assessment tools revealed 
correlation coefficients of variable significance. Extensor spasms correlated highly with Ashworth scores, 
whereas flexor spasms and clonus scores correlated to a lesser extent. 
The SCATS may have advantages over previously used measures of spastic hypertonia for subjects with SCI. The 
clinical scales most widely used by clinicians, in particular the Ashworth Scale and the MAS, classify spasticity as 
a single-joint, velocity-dependent resistance to movement. Although these scales provide valid estimates of 
spastic hypertonia, their reliability has been questioned.10, 20, 21 In addition, multijoint flexor and extensor 
spasms, which are prevalent in SCI, are not accounted for in the Ashworth Scale and MAS. The SCATS is a more 
comprehensive clinical scale for spastic hypertonia in SCI that includes measurements of multijoint spastic motor 
behaviors. As a result, the SCATS provides additional valuable information about the occurrence of different 
types of spastic motor behaviors, and the incidence of different components of the SCATS may reflect patient-
specific physiologic differences. 
The PSFS is a more general scale than the Ashworth, and theoretically it includes many types of spastic motor 
behaviors. Surprisingly, the PSFS only correlated significantly with SCATS clonus scores, which may indicate a 
substantial role of clonus in the perception of the occurrence of spasms. These results suggest that the PSFS 
does not adequately record flexor and extensor spasms, which may only be triggered during specific ADLs. 
Flexor and extensor spasms may be used by patients to assist in functional tasks in a somewhat controlled 
manner and thus may not be included in the patient reports. These observations suggest that the PSFS is useful 
for identifying the frequency of problem-causing spasms; however, it does not appear to distinguish between 
the types of spastic reflexes that are elicited. As a result, it would be beneficial for clinicians to gather more data 
from both measures. 
Although the SCATS reliably distinguishes between different types and severity of spastic reflexes in SCI and can 
be administered quickly in the clinic, it ideally should be combined with other measures. For example, the SCATS 
fails to account for the patient’s own perspective of the severity of spasticity. We propose that the SCATS be 
integrated into a multidimensional approach to the evaluation of spastic hypertonia by using patient and 
clinician reports. This approach would provide both objective measures of spastic hypertonia and subjective, 
patient-based information that could be acquired within a timeframe appropriate for a clinical setting.11 The 
SCATS augments the data provided by the Ashworth Scale and the PSFS by providing information about the type 
of spastic hypertonia and the underlying physiology. 
Because of the variability of SCATS scores among subjects, differences in manifestation of spastic motor 
behaviors likely reflect differences in the pathophysiologic mechanisms that underlie the spasms. For example, 
clonus is believed to occur when there is recurrent excitation of a hyperactive stretch reflex and/or activity of a 
central oscillator that excites the motor neurons.8, 22, 23 Conversely, flexor spasms are often triggered by 
cutaneous stimuli and may be attributed to an increased excitability of the interneurons of the flexor 
reflex pathway.13, 24 The association of flexor spasms with the flexion withdrawal reflex has been shown by 
decreased thresholds for activation of the flexion withdrawal reflex in SCI and by the presence of a large 
amplitude and duration of flexor muscle activity when a cutaneous stimulus is applied.13 Finally, extensor 
spasms, which are often triggered by extension of the hips,3 may be mediated by increased excitability of the 
interneuronal circuitry normally used for increasing limb stiffness during standing or during the stance phase of 
locomotion.15 The SCATS provides a mechanism to accurately assess targeted spastic behaviors that are 
associated with specific physiologic mechanisms. 
Improved understanding of the predominant types of spastic motor behaviors is important to spasticity 
management, because different types of spasms have been found to interfere with functional mobility in various 
ways. Patients report that clonus interferes with function primarily associated with wheelchair propulsion and 
transfers. Flexor spasms are reported to interfere with function during sleep, bed positioning, and 
transfers.3, 6 Flexor spasms have also been clinically observed to interfere with ambulation. Extensor spasms, 
which occur most frequently, cause the most discomfort and produce the greatest interference with function 
during transfers and wheelchair propulsion.3, 6 However, people have also reported that extensor spasms can 
be helpful, especially when performing lower-extremity dressing. 
We believe that knowledge of the type of spastic motor behaviors and its severity will facilitate informed 
decisions about the administration of pharmacologic and physical treatment approaches. For example, clinical 
practice suggests that clonus can be minimized by positioning a footplate on the wheelchair that puts the ankle 
at an angle past that at which the hyperactive reflex is elicited (≈2° from maximum dorsiflexion).25 Furthermore, 
evaluation of force distribution along the plantar aspect of the foot when prescribing shoes or ankle-
foot orthoses could minimize flexor spasms. Extensor spasms may be minimized by changes in the wheelchair 
seat angle (dump), to ensure that hip angle does not change during wheelchair propulsion, on uneven terrain, or 
with upper-extremity activity. In addition, alternative transfer techniques that do not require a change in hip 
angle could be implemented. With a greater understanding of the physiologic mechanisms underlying spasms 
and spastic hypertonia, and with clinical tools designed to assess accurately the various motor patterns seen 
after SCI, effective pharmacologic interventions can be prescribed. For instance, knowledge of whether the 
spasms are related to motoneuronal or interneuronal hyperexcitability may enable targeting of specific 
serotonergic or noradrenergic pathways.24 During pharmacologic treatment, the SCATS could also be used, as 
clinicians use the Ashworth Scale, to assess the efficacy of the drug.26, 27, 28 
It should also be noted that the SCATS is intended primarily for people with SCI and may not be suitable for use 
with other populations that exhibit spastic hypertonia such as those with traumatic brain injury, stroke, 
or cerebral palsy. The extensor and flexor reflexes that are common in SCI are less prominent in people with 
more cephelad injuries. 
Conclusions 
The SCATS provides a valid method for measuring spastic motor behaviors in the clinical setting and 
distinguishes among different types and severity of spastic reflexes. The SCATS may be a useful adjunct to self-
report scales and may have a significant impact on guiding both functional and pharmacologic management 
of spasticity in SCI. 
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